Manuscripts
Showing 1519 manuscripts.
Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial
Citation
Lynda Stranix-Chibanda, Camlin Tierney, Dorothy Sebikari , Jim Aizire, Sufia Dadabhai, Admire Zanga, Cynthia Mukwasi-Kahari, Tichaona Vhembo, Avy Violari, Gerard Theron, Dhayandre Moodley , Kathleen George, Bo Fan, Markus J Sommer, Renee Browning, Lynne M Mofenson, John Shepherd, Bryan Nelson, Mary Glenn Fowler, George K Siberry , PROMISE P1084s study team. Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial. PLoS One. 2021. 16: e0246272. PMID: 33544759Journal
PLoS One
Study
P1084s
Impact of Low Birth Weight and Prematurity on Neonatal Raltegravir Pharmacokinetics: Impaact P1097
Citation
Diana F Clarke, Jos Lommerse, Edward P Acosta, Mae P Cababasay, Jiajia Wang, Stephen A Spector, Anne Chain, Elizabeth Smith, Hedy Teppler, Rohan Hazra, Kat Calabrese, Bobbie Graham, Stephanie Popson, Yvonne Bryson, Mark Mirochnick, International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1097 Study Team. Impact of Low Birth Weight and Prematurity on Neonatal Raltegravir Pharmacokinetics: Impaact P1097. Journal of Acquired Immune Deficiency Syndromes. 2020. 85: 626-634. PMID: 32925360Year
2022
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1097
Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy
Citation
Engie Salama, Ahizechukwu C Eke, Brookie M Best, Mark Mirochnick, Jeremiah D Momper. Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy. Journal of Clinical Pharmacology. 2020. 60: 1537-1550. PMID: 32798276Year
2022
Journal
Journal of Clinical Pharmacology
Study
P1026S
Time to Treatment Disruption in Children on Initial Protease Inhibitor vs. Non-Nucleoside Reverse Transcriptase Inhibitor Regimens
Citation
D Yin, C Ludema, S Cole, C Golin, W Miller, M Warshaw, R McKinney ; on behalf of the PENPACT-1 (PENTA 9 / PACTG 390) Study Team. Time to Treatment Disruption in Children on Initial Protease Inhibitor vs. Non-Nucleoside Reverse Transcriptase Inhibitor Regimens. AIDS. 2020. PMID: 33226999Journal
AIDS
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling
Citation
Xiaomei I Liu, Jeremiah D Momper, Natella Y Rakhmanina, Dionna J Green, Gilbert J Burckart, Tim R Cressey, Mark Mirochnick, Brookie M Best, John N van den Anker, André Dallmann. Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling. Clinical Pharmacokinetics. 2020. 59: 1433-1450. PMID: 32451908Journal
Clinical Pharmacokinetics
Study
P1026S
African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus
Citation
Michael J. Boivin, Miriam Chernoff, Barbara Laughton, Bonnie Zimmer, Celeste Joyce, Linda Barlow-Mosha, Mutsa Bwakura-Dangarembizi, Tichaona Vhembo, Mmule Ratswana, Portia Kamthunzi, Katie McCarthy, Itziar Familiar-Lopez, Patrick Jean-Philippe, Joan Coetzee, Nasreen Abrahams, Hermien Gous, Avy Violari, Mark F. Cotton, Paul Palumbo, IMPAACT P1104s Study Team. African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus. Clinical Infectious Diseases. 2020. 71: e105-e114. PMID: 31848582Journal
Clinical Infectious Diseases
Study
P1104s
Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping
Citation
Kamunkhwala Gausi, Lubbe Wiesner, Jennifer Norman, Carole L Wallis, Carolyne Onyango-Makumbi, Tsungai Chipato, David W Haas, Renee Browning, Nahida Chakhtoura, Grace Montepiedra, Lisa Aaron, Katie McCarthy, Sarah Bradford, Tichaona Vhembo, Lynda Stranix-Chibanda, Gaerolwe R Masheto, Avy Violari, Blandina T Mmbaga, Linda Aurpibul, Ramesh Bhosale, Neetal Nevrekhar, Vanessa Rouzier, Enid Kabugho, Mercy Mutambanengwe, Vongai Chanaiwa, Mandisa Nyati, Tsungai Mhembere, Fuanglada Tongprasert, Anneke Hesseling, Katherine Shin, Bonnie Zimmer, Diane Costello, Patrick Jean-Philippe, Timothy R Sterling, Gerhard Theron, Adriana Weinberg, Amita Gupta, Paolo Denti, IMPAACT P1078 (TB APPRISE) Study Group Team. Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping. Clinical Pharmacology & Therapeutics. 2020. PMID: 32909316Year
2022
Journal
Clinical Pharmacology & Therapeutics
Study
P1078
Alendronate Improves Bone Mineral Density in Children and Adolescents Perinatally Infected With Human Immunodeficiency Virus With Low Bone Mineral Density for Age
Citation
Denise L Jacobson, Jane C Lindsey, Catherine Gordon, Rohan Hazra, Hans Spiegel, Flavia Ferreira, Fabiana R Amaral, Jesica Pagano-Therrien, Aditya Gaur, Kathy George, jane Benson, George K Siberry. Alendronate Improves Bone Mineral Density in Children and Adolescents Perinatally Infected With Human Immunodeficiency Virus With Low Bone Mineral Density for Age. Clinical Infectious Diseases. 2020. 71: 1281-1288. PMID: 31573608Journal
Clinical Infectious Diseases
Study
P1076
Enrollment and transition challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) network's PROMISE trial for resource-limited regions
Citation
Konstantia Angelidou, Mary Glenn Fowler, Pat Flynn, Anne Coletti, Katie McCarthy, Renee Browning, James McIntyre, Sean S Brummel, David E Shapiro, Camlin Tierney, PROMISE study team. Enrollment and transition challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) network's PROMISE trial for resource-limited regions. Clinical Trials. 2020. 17: 437-447. PMID: 32191142Journal
Clinical Trials
Study
1077BF, 1077FF, 1077HS
Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants
Citation
CK Cunningham, EJ McFarland, RL Morrison, EV Capparelli, JT Safrit, LM Mofenson, B Mathieson, ME Valentine, C Perlowski, B Smith, R Hazra, L Purdue, P Muresan, PA Harding, T Mbengeranwa, LG Robinson, A Wiznia, G Theron, B Lin, RT Bailer, JR Mascola, BS Graham, IMPAACT P1112 team. Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants. Journal of Infectious Diseases. 2020. 222: 628-636. PMID: 31681963Journal
Journal of Infectious Diseases
Study
P1112